Insider Trading activities at Relmada Therapeutics, Inc. (RLMD)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Relmada Therapeutics, Inc. (RLMD) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Relmada Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1553643.

Total stock buying since 2015: $2,682,571.
Total stock sales since 2015: $10,242,619.
Total stock option exercises since 2015: $3,078,452.


8 insiders reported insider trading activities at Relmada Therapeutics, Inc. (RLMD):
Insider trading activities of Traversa Sergio
Insider trading activities of O'gorman Cedric
Insider trading activities of Shenouda Maged
Insider trading activities of Ence Chuck
Insider trading activities of Kelly Paul Edward
Insider trading activities of Seth Sandesh
Insider trading activities of Agharkar Shreeram
Insider trading activities of Casamento Charles J

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Relmada Therapeutics, Inc. (RLMD).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 1,244,937 $639,346 0 $0 0 $0
2024 403,077 $1,306,232 0 $0 0 $0
2023 10,000 $31,800 0 $0 0 $0
2022 55,250 $115,804 59,567 $1,435,195 79,567 $637,624
2021 0 $0 129,900 $8,152,288 164,559 $1,857,206
2020 0 $0 18,000 $655,136 98,370 $318,717
2019 105,978 $267,944 0 $0 67,578 $264,905
2018 155,000 $141,065 0 $0 0 $0
2015 59,700 $180,380 0 $0 0 $0

Table 2. Monthly summary of insider trading at Relmada Therapeutics, Inc. (RLMD).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-08 265,976 $178,093 0 $0 0 $0
2025-05 978,961 $461,253 0 $0 0 $0
2024-09 231,432 $642,843 0 $0 0 $0
2024-01 171,645 $663,389 0 $0 0 $0
2023-05 10,000 $31,800 0 $0 0 $0
2022-12 55,250 $115,804 0 $0 0 $0
2022-07 0 $0 13,755 $253,325 13,755 $220,080
2022-06 0 $0 16,012 $307,270 16,012 $256,192
2022-04 0 $0 29,800 $874,600 29,800 $96,552
2022-01 0 $0 0 $0 20,000 $64,800
2021-09 0 $0 6,600 $191,400 10,000 $46,000
2021-08 0 $0 0 $0 10,000 $46,000
2021-07 0 $0 3,300 $104,798 0 $0
2021-05 0 $0 3,000 $114,648 0 $0
2021-03 0 $0 28,000 $993,039 25,000 $81,000
2021-02 0 $0 55,845 $1,951,057 89,404 $303,465
2021-01 0 $0 33,155 $4,797,346 30,155 $1,380,741
2020-12 0 $0 3,000 $107,220 0 $0
2020-11 0 $0 3,000 $90,864 0 $0
2020-10 0 $0 3,000 $113,955 0 $0
2020-09 0 $0 3,000 $104,207 0 $0
2020-08 0 $0 3,000 $107,214 98,370 $318,717
2020-07 0 $0 3,000 $131,676 0 $0
2019-12 0 $0 0 $0 67,578 $264,905

Table 3. Detailed insider trading at Relmada Therapeutics, Inc. (RLMD)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-08-28 Traversa Sergio (Chief Executive Officer) Buy 55,976 .74 41,422
2025-08-27 Traversa Sergio (Chief Executive Officer) Buy 129,455 .67 86,734
2025-08-26 Traversa Sergio (Chief Executive Officer) Buy 80,545 .62 49,937
2025-05-20 Shenouda Maged (Chief Financial Officer) Buy 60,000 .52 31,440
2025-05-20 Traversa Sergio (Chief Executive Officer) Buy 147,686 .56 82,261
2025-05-19 Shenouda Maged (Chief Financial Officer) Buy 90,000 .48 43,650
2025-05-19 Traversa Sergio (Chief Executive Officer) Buy 30,000 .50 15,000
2025-05-16 Ence Chuck (CA and CO) Buy 228,961 .45 103,261
2025-05-16 Kelly Paul Edward (Chief Operating Officer) Buy 200,000 .43 86,000
2025-05-16 Shenouda Maged (Chief Financial Officer) Buy 50,000 .44 22,100
2025-05-16 Traversa Sergio (Chief Executive Officer) Buy 172,314 .45 77,541
2024-09-11 Shenouda Maged (Chief Financial Officer) Buy 24,120 2.95 71,154
2024-09-11 Traversa Sergio (Chief Executive Officer) Buy 51,407 2.99 153,706
2024-09-10 Shenouda Maged (Chief Financial Officer) Buy 21,118 2.73 57,652
2024-09-10 Traversa Sergio (Chief Executive Officer) Buy 33,014 2.75 90,788
2024-09-09 Kelly Paul Edward Buy 25,000 2.59 64,750
2024-09-09 Shenouda Maged (Chief Financial Officer) Buy 8,194 2.55 20,894
2024-09-09 Traversa Sergio (Chief Executive Officer) Buy 55,579 2.71 150,619
2024-09-09 Casamento Charles J Buy 13,000 2.56 33,280
2024-01-31 Ence Chuck (CA and CO) Buy 13,670 4.05 55,431
2024-01-31 Shenouda Maged (Chief Financial Officer) Buy 6,875 4.07 27,946
2024-01-31 Traversa Sergio (Chief Executive Officer) Buy 27,460 4.00 109,757
2024-01-30 Ence Chuck (CA and CO) Buy 14,500 3.87 56,057
2024-01-30 Shenouda Maged (Chief Financial Officer) Buy 15,000 3.89 58,320
2024-01-30 Traversa Sergio (Chief Executive Officer) Buy 40,999 3.90 159,937
2024-01-29 Ence Chuck (CA and CO) Buy 10,800 3.65 39,441
2024-01-29 Shenouda Maged (Chief Financial Officer) Buy 10,800 3.65 39,452
2024-01-29 Traversa Sergio (Chief Executive Officer) Buy 31,541 3.71 117,048
2023-05-23 O'gorman Cedric (Chief Medical Officer) Buy 10,000 3.18 31,800
2022-12-08 Traversa Sergio (Chief Executive Officer) Buy 55,250 2.10 115,804
2022-07-01 Traversa Sergio (Chief Executive Officer) Sale 13,755 18.42 253,325
2022-07-01 Traversa Sergio (Chief Executive Officer) Option Ex 13,755 16.00 220,080
2022-06-30 Traversa Sergio (Chief Executive Officer) Sale 16,012 19.19 307,270
2022-06-30 Traversa Sergio (Chief Executive Officer) Option Ex 16,012 16.00 256,192
2022-04-04 Kelly Paul Edward Sale 10,000 30.04 300,400
2022-04-04 Kelly Paul Edward Option Ex 10,000 3.24 32,400
2022-04-01 Casamento Charles J Sale 19,800 29.00 574,200
2022-04-01 Casamento Charles J Option Ex 19,800 3.24 64,152
2022-01-03 Kelly Paul Edward Option Ex 20,000 3.24 64,800
2021-09-22 Casamento Charles J Sale 6,600 29.00 191,400
2021-09-22 Casamento Charles J Option Ex 10,000 4.60 46,000
2021-08-17 Casamento Charles J Option Ex 10,000 4.60 46,000
2021-07-15 Casamento Charles J Sale 3,300 31.76 104,798
2021-05-03 Casamento Charles J Sale 3,000 38.22 114,648
2021-03-10 Shenouda Maged (CFO) Sale 2,373 35.11 83,313
2021-03-10 Traversa Sergio (CEO) Sale 2,983 35.09 104,676
2021-03-09 Kelly Paul Edward Sale 5,000 35.87 179,355
2021-03-09 Kelly Paul Edward Option Ex 5,000 3.24 16,200
2021-03-09 Shenouda Maged (CFO) Sale 7,527 35.72 268,871
2021-03-09 Traversa Sergio (CEO) Sale 7,017 35.87 251,706
2021-03-09 Traversa Sergio (CEO) Option Ex 10,000 3.24 32,400
2021-03-08 Shenouda Maged (CFO) Sale 100 35.00 3,500
2021-03-08 Shenouda Maged (CFO) Option Ex 10,000 3.24 32,400
2021-03-01 Casamento Charles J Sale 3,000 33.87 101,618
2021-02-24 Kelly Paul Edward Sale 5,000 34.63 173,145
2021-02-24 Kelly Paul Edward Option Ex 5,000 3.24 16,200
2021-02-24 Traversa Sergio (CEO) Sale 10,000 34.65 346,470
2021-02-24 Traversa Sergio (CEO) Option Ex 10,000 3.24 32,400
2021-02-16 Kelly Paul Edward Option Ex 5,000 6.00 30,000
2021-02-11 Shenouda Maged (CFO) Sale 1,428 35.39 50,542
2021-02-11 Shenouda Maged (CFO) Option Ex 1,428 3.24 4,626
2021-02-11 Traversa Sergio (CEO) Sale 1,446 35.44 51,239
2021-02-11 Traversa Sergio (CEO) Option Ex 1,446 3.24 4,685
2021-02-10 Shenouda Maged (CFO) Sale 2,410 35.20 84,824
2021-02-10 Traversa Sergio (CEO) Sale 1,930 35.28 68,098
2021-02-09 Kelly Paul Edward Sale 2,069 35.28 73,004
2021-02-09 Shenouda Maged (CFO) Sale 5,359 35.24 188,845
2021-02-09 Traversa Sergio (CEO) Sale 5,963 35.21 209,939
2021-02-08 Kelly Paul Edward Sale 1,500 35.04 52,560
2021-02-08 Kelly Paul Edward Option Ex 3,569 3.24 11,563
2021-02-08 Shenouda Maged (CFO) Sale 3,603 35.04 126,241
2021-02-08 Shenouda Maged (CFO) Option Ex 11,372 3.24 36,845
2021-02-08 Traversa Sergio (CEO) Sale 3,313 35.03 116,047
2021-02-08 Traversa Sergio (CEO) Option Ex 11,206 3.24 36,307
2021-02-03 Shenouda Maged (CFO) Sale 100 35.00 3,500
2021-02-03 Traversa Sergio (CEO) Sale 100 35.00 3,500
2021-02-02 Kelly Paul Edward Sale 2,315 35.04 81,117
2021-02-02 Shenouda Maged (CFO) Sale 3,100 35.04 108,633
2021-02-02 Shenouda Maged (CFO) Option Ex 3,200 3.24 10,368
2021-02-02 Traversa Sergio (CEO) Sale 3,178 35.08 111,468
2021-02-02 Traversa Sergio (CEO) Option Ex 16,559 3.24 53,650
2021-02-01 Kelly Paul Edward Sale 31 35.00 1,085
2021-02-01 Kelly Paul Edward Option Ex 17,346 3.24 56,201
2021-02-01 Casamento Charles J Sale 3,000 33.60 100,800
2021-01-27 Kelly Paul Edward Sale 5,000 32.66 163,299
2021-01-27 Kelly Paul Edward Option Ex 5,000 3.24 16,200
2021-01-27 Shenouda Maged (CFO) Sale 3,000 32.01 96,030
2021-01-27 Shenouda Maged (CFO) Option Ex 3,000 3.24 9,720
2021-01-27 Traversa Sergio (CEO) Sale 10,000 32.69 326,870
2021-01-27 Traversa Sergio (CEO) Option Ex 10,000 3.24 32,400
2021-01-26 Kelly Paul Edward Sale 685 35.16 24,084
2021-01-26 Shenouda Maged (CFO) Sale 607 35.16 21,342
2021-01-26 Traversa Sergio (CEO) Sale 600 35.15 21,090
2021-01-25 Kelly Paul Edward Sale 1,300 35.27 45,851
2021-01-25 Shenouda Maged (CFO) Sale 1,280 35.27 45,145
2021-01-25 Traversa Sergio (CEO) Sale 1,300 35.29 45,877
2021-01-22 Kelly Paul Edward Sale 2,100 1,789.59 3,758,139
2021-01-22 Kelly Paul Edward Option Ex 4,085 3.24 13,235
2021-01-22 Shenouda Maged (CFO) Sale 2,113 35.78 75,603
2021-01-22 Shenouda Maged (CFO) Option Ex 4,000 324.00 1,296,000
2021-01-22 Traversa Sergio (CEO) Sale 2,170 35.80 77,675
2021-01-22 Traversa Sergio (CEO) Option Ex 4,070 3.24 13,186
2021-01-04 Casamento Charles J Sale 3,000 32.11 96,341
2020-12-01 Casamento Charles J Sale 3,000 35.74 107,220
2020-11-02 Casamento Charles J Sale 3,000 30.29 90,864
2020-10-01 Casamento Charles J Sale 3,000 37.98 113,955
2020-09-01 Casamento Charles J Sale 3,000 34.74 104,207
2020-08-18 Kelly Paul Edward Option Ex 22,000 3.24 71,280
2020-08-18 Traversa Sergio (CEO) Option Ex 50,008 3.24 162,025
2020-08-18 Casamento Charles J Option Ex 26,362 3.24 85,412
2020-08-03 Casamento Charles J Sale 3,000 35.74 107,214
2020-07-01 Casamento Charles J Sale 3,000 43.89 131,676
2019-12-24 Casamento Charles J Option Ex 67,578 3.92 264,905
2019-10-21 Shenouda Maged Buy 978 23.00 22,494
2019-10-18 Kelly Paul Edward Buy 5,000 19.09 95,450
2019-05-14 Kelly Paul Edward Buy 100,000 1.50 150,000
2018-12-11 Kelly Paul Edward Buy 5,000 1.21 6,065
2018-10-12 Kelly Paul Edward Buy 150,000 .90 135,000
2015-12-31 Agharkar Shreeram Buy 400 2.50 1,000
2015-12-16 Agharkar Shreeram Buy 1,100 3.35 3,685
2015-12-15 Shenouda Maged Buy 3,000 2.99 8,970
2015-12-15 Seth Sandesh Buy 9,500 3.23 30,666
2015-12-15 Traversa Sergio (Chief Executive Officer) Buy 18,970 3.15 59,755
2015-12-14 Kelly Paul Edward Buy 10,000 2.84 28,400
2015-12-14 Shenouda Maged Buy 2,000 2.89 5,780
2015-12-14 Seth Sandesh Buy 10,500 2.82 29,620
2015-12-14 Traversa Sergio (Chief Executive Officer) Buy 30 2.97 89
2015-12-14 Casamento Charles J Buy 4,200 2.96 12,415

Insider trading activities including stock purchases, stock sales, and option exercises of RLMD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Relmada Therapeutics, Inc. (symbol RLMD, CIK number 1553643) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.